Key result
Acute pulmonary embolism carries a ~22% 5-year all-cause mortality, split evenly between CV and non-CV causes.
Why the study?
Long-term cause-specific mortality, temporal changes in causes of death, and associated factors after acute PE remain poorly characterized.
Cohort (n=66,192)
Yes
In a large nationwide Chinese cohort of patients hospitalized with acute pulmonary embolism, 5-year cumulative mortality was 22.41%, with nearly half of deaths attributable to non-cardiovascular causes and ischemic heart disease emerging as the leading cardiovascular cause of death.
Answers are grounded in this paper and cite their sources.
High 5-year mortality after acute PE hospitalization warrants comprehensive follow-up; leaves open targeted strategies in observational cohorts.
Background and Aims Long-term cause-specific mortality after acute pulmonary embolism (PE) remains poorly characterized. This study investigated cumulative mortality, temporal changes in causes of death, and associated factors in a national registry. Methods This registry-based cohort study consecutively enrolled 66 192 acute PE patients from 3223 Chest Pain Centres across China (2018-2023) (ClinicalTrials.gov: NCT04014972). Mortality was ascertained through national registry linkage. Cumulative incidence functions estimated temporal mortality patterns, while Fine-Gray models exploratorily examined factors associated with cause-specific mortality. Results At 60 months, cumulative all-cause mortality was 22.41% (95% confidence interval [CI] 21.92-22.91), comprising cardiovascular (CV) (11.84%, 95% CI 11.46-12.23) and non-CV mortality (10.57%, 95% CI 10.22-10.92). Causes of death varied over time: acute PE and ischaemic heart disease (IHD) predominated initially, malignancy peaked at 1-3 months, and IHD was the largest named cause in each interval beyond 12 months. Among CV deaths, IHD was the predominant cause (35.7%); malignancy (43.3%) and chronic pulmonary disease (24.6%) predominated among non-CV deaths. Men had higher cumulative CV and non-CV mortality than women; while women only had a higher proportion of CV causes among deaths. All-cause mortality increased with age (from 11.52% at <55 to 38.51% at ≥75 years); acute PE/malignancy dominated in younger patients, while CV/pulmonary disease prevailed in older ones. Exploratory analyses identified age, Western China residence, and vital signs as factors associated with mortality. Conclusions Among patients hospitalised with acute PE, 5-year cumulative mortality was 22.4%, and nearly half of deaths were from non-CV causes. Shifting mortality patterns highlight the need to evaluate risk-adapted long-term follow-up strategies.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) conducted a cohort in Acute pulmonary embolism (n=66,192). Acute pulmonary embolism was evaluated on 60-month cumulative all-cause mortality (95% CI 21.92-22.91). Patients hospitalized with acute pulmonary embolism had a 60-month cumulative all-cause mortality of 22.41%, including 11.84% CV and 10.57% non-CV mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: